Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2026-01-03 @ 7:26 AM
Study NCT ID:
NCT00614835
Status:
COMPLETED
Last Update Posted:
2015-12-22
First Post:
2008-01-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-08
Start Date Type:
None
Primary Completion Date:
2006-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-31
First Submit QC Date:
None
Study First Post Date:
2008-02-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-21
Last Update Post Date:
2015-12-22
Last Update Post Date Type:
ESTIMATED